BioSpace News Archive

Pharming Group Elects to Redeem Fifth Tranche of Convertible Bond for Cash

June 24, 2013
·
3 min read
Drug Development

Sanofi (France) Announces Positive Phase 3 Results for Investigational New Insulin U300

June 24, 2013
·
11 min read
Bio NC

The ROMaN Project, Inc. Release: the First Comprehensive Remote Monitoring Solution for the Clinical Trial Industry

June 24, 2013
·
2 min read
Drug Development

Janssen Research & Development Release: Studies Reinforce INVOKANA™ (canagliflozin) (300mg) Provides Greater Improvements in Blood Glucose Than Sitagliptin (100 mg) or Glimepiride (6 or 8 mg) in Adults With Type 2 Diabetes

June 24, 2013
·
16 min read
Aircraft Medical Puts Competitors on Notice of 70 Patents and Design Rights in Key Video Laryngoscope Markets

June 24, 2013
·
1 min read
Quintiles, Inc. Named Britain’s Healthiest Large Company

June 24, 2013
·
1 min read
BioForest

BioLife Solutions, Inc. Named One of Washington’s Best Companies

June 24, 2013
·
3 min read
Drug Development

Nuvilex’s Phase III Pancreatic Cancer Trials Could Address New Law’s Call for Progress

June 24, 2013
·
2 min read
Drug Development

Lexicon Pharmaceuticals, Inc. Presents Preclinical Data on LX2761, a New Clinical Candidate for Diabetes Designed to Reduce Glucose Absorption From Gastrointestinal Tract

June 24, 2013
·
4 min read
Pharm Country

Animas Corporation Makes Progress in Development of a First-Generation Closed-Loop Insulin Delivery System With Study Participants Maintaining Safe Glucose Levels for Over 90 Percent of the Overnight Period

June 24, 2013
·
4 min read